The differences in the metabolic profile, neuroinflammation and neurodegeneration between CRY2-Aβ-mCherry and CRY2-Tau-mCherry will shed light on the distinct pathophysiology of Aβ and tau aggregates in AD. This evidence concerns the gene MAPT and Alzheimer disease.